Off‐label biologic treatments in refractory inflammatory scarring alopecia
- 13 February 2024
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 38 (8) , e708-e710
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Successful treatment of dissecting cellulitis with certolizumab pegol in a pregnant patientJAAD Case Reports, 2023
- Therapy‐refractory folliculitis decalvans treated with certolizumab pegolInternational Journal of Dermatology, 2021
- Recalcitrant Dissecting Cellulitis of the Scalp Treated Successfully with Adalimumab with Hair Regrowth: A Case ReportClinical, Cosmetic and Investigational Dermatology, 2021
- Recalcitrant lichen planopilaris and frontal fibrosing alopecia responding to tildrakizumabDermatologic Therapy, 2020
- Treatment of refractory dissecting cellulitis of the scalp with guselkumab: Case reportJournal of Dermatology and Dermatologic Surgery, 2020
- Successful treatment of refractory folliculitis decalvans with secukinumabAustralasian Journal of Dermatology, 2019